News
Bloomberg on MSN13d
Goldman's Oppenheimer: 'Growing Opportunities' in EuropePeter Oppenheimer, chief global equity strategist at Goldman Sachs, says the prospect of looser monetary and fiscal policy in ...
Hosted on MSN20d
Equity investors should focus more on beta than alpha, says Goldman Sachs' Peter OppenheimerPeter Oppenheimer, Goldman Sachs chief global equity strategist, joins 'Money Movers' to discuss investing in international markets as the U.S. dollar continues to face pressure. New Poll Reveals ...
In a new note titled "What to do after the rally," Goldman Sachs global equity strategist Peter Oppenheimer poses the pertinent question for investors now that the swift gains from a relief rally ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...
Goldman Sachs analysts on Friday also cut their estimates for second-quarter handovers and the stock price target ...
Detailed price information for Urogen Pharma Ltd (URGN-Q) from The Globe and Mail including charting and trades.
However, Goldman Sachs strategists, including global equity strategist Peter Oppenheimer, believe the SPDR® S&P 500® ETF Trust (NYSE:SPY) faces enough tail risks to potentially fall by up to 20% ...
Goldman Sachs global strategist Peter Oppenheimer says we can be pretty confident the event-driven bear market we briefly saw last month will not turn into a cyclical one, thanks to the onset of ...
Due to high demand, the stablecoin issuer increased its IPO from a planned 24 million shares. Circle is now worth anywhere ...
Chef Eric Sifu has created a special menu At KOKO to represent flavours from China’s Sichuan province. Chef Nak is on a ...
Technical signals are also strong, with the price trading above the 50- and 200-day simple moving averages (SMAs) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results